Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Springer Nature Switzerland AG, 2019
172,25 €On orderDelivery: 2-3 weeks
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.
- ISBN-13
- 9783030098179
- ISBN-10
- 3030098176
- Publisher
- Springer Nature Switzerland AG
- Year
- 2019
- Publication date
- 2019-02-02
- Pages
- 242
- Dimensions
- 235x155x